TotalSeq™-B1159 anti-human IL-16, IL-16, 14.1,BioLegend,519109

Additional reported applications (for the relevant formats) include: ELISA2, inhibition of T cell chemotaxis2and immunohistochemical staining of frozen lymph node sections3.

Host

Mouse

Reactivity

Human

Application

ICPG - Quality tested

Platform ID

BAB977588907

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B1159 anti-human IL-16, IL-16, 14.1
Cat. No.519109
HostMouse
RRIDAB_3699058 (BioLegend Cat. No. 519109)
IsotypeMouse IgG2a
ReactivityHuman
ApplicationICPG - Quality tested
ClonalityMonoclonal
Clone Number14.1
Concentration0.5 mg/mL
TargetIL-16
ImmunogenPeptide corresponding to amino acids 615 to 630 (RRKSLQSKETTAAGDS) of IL-16
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

Interleukin-16 is a proinflammatory cytokine synthesized as a 68 kD precursor molecule (pro-IL-16). After cleavage of pro-IL-16 by caspase-3, IL-16 is released as a 12 kD protein, but its biologic activities are exerted by a tetramer. IL-16 is a chemoattractant for CD4+T cells, monocytes, and eosinophils. On T cells, IL-16 upregulates CD25 and class II expression, and also inhibits HIV-1 replicationin vitroby repressing the transcription of the HIV-1 long terminal repeat. IL-16 is expressed by lymphocytes, macrophages, eosinophils, mast cells, epithelial cells, and fibroblasts. CD4 and CD9 are the receptors of IL-16.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.